期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

血清内脂素与急性冠状动脉综合征的相关性

Study on the relationship between serum visfatin levels and acute coronary syndrome
暂未订购
导出
摘要 目的:探讨血清内脂素与急性冠状动脉综合征(ACS)的关系及其在斑块失稳定性中的作用。方法:采用ELISA方法分别检测40例ACS(ACS组)、22例稳定型心绞痛(SAP组)和26例非冠心病患者(对照组)的血清内脂素及基质金属蛋白酶-9(MMP-9)水平,并比较两者相关性。结果:ACS组血清内脂素和MMP-9水平均显著高于SAP组和对照组(P<0.01)。ACS患者中血清内脂素与MMP-9呈显著正相关关系(P<0.01)。结论:血清内脂素与ACS具有相关性,可作为预测斑块稳定性的标志物,对其测定有助于ACS的早期防治。 Objective：To study the relationship of serum visfatin levels and acute coronary syndrome（ACS） and the role of serum visfatin in vulnerable plaques.Methods：The serum levels of visfatin and matrix metalloproteinase-9（MMP-9） in 40 cases with ACS,22 cases with stable angina pectoris（SAP） and 26 control cases were measured by ELISA,and the correlation between visfatin and MMP-9 was evaluated.Results：The levels of visfatin and MMP-9 in cases with ACS were significantly higher than those in SAP and control groups（P0.01）.Significant positive correlation of visfatin and MMP-9 in patients with ACS were found（P0.01）.Conclusions：The serum levels of visfatin and ACS exist correlation.Visfatin may act as the biomarkers of vulnerable plaques and be applied in the early prevention and management of ACS.
作者 华启洋 张宁汝 周桂建 张恒
机构地区 江苏省昆山市第四人民医院内科 蚌埠医学院第一附属医院心血管科
出处 《蚌埠医学院学报》 CAS 2011年第12期1341-1342,1345,共3页 Journal of Bengbu Medical College
关键词 冠状动脉疾病 急性冠状动脉综合征 内脂素 基质金属蛋白酶-9 易损斑块 coronary disease acute coronary syndrome visfatin matrix metalloproteinase-9 vulnerable plaques
分类号 R543.3 [医药卫生—心血管疾病]
  • 相关文献

参考文献9

  • 1Fukuhara A,Matsuda M,Nishizawa M,et al.Visfatin:a protein secreted by visceral fat that mimics the effects of insulin[J].Science,2005,307(5708):426-430.
  • 2Chang YC,Chang TJ,Lee WJ,et al.The relationship of visfatin/pre-B-cell colony-enhancing factor/nicotinamide phosphoribosyltransferase in adipose tissue with inflammation,insulin resistance,and plasma lipids[J].Metabolism,2010,59(1):93-99.
  • 3Chen MP,Chung FM,Chang DM,et al.Elevated plasma level of visfatin/pre-B-cell colony-enhancing factor in patients with type 2 diabetes mellitus[J].Clin Endocfino1 Metab,2006,91(1):295-299.
  • 4Kim SR,Bae YH,Bae SK,et al.Visfatin enhances ICAM-1 and VCAM-1 expression through ROS-dependent NF-kappaB activation in endothelial cells[J].Biochim Biophys Acta 2008,1783(5):886-895.
  • 5Liu SW,Qiao SB,Yuan JS,et al.Visfatin stimulates production of monocyte chemotactic protein-1 and interleukin-6 in human vein umbilical endothelial cells[J].Horm Metab Res,2009,41(4):281-286.
  • 6van der Veer E,Nong Z,O′Neil C,et al.Pre-B-cell colony-enhancing factor regulates NAD+-dependent protein deacetylase activity and promotes vascular smooth muscle cell maturation[J].Circ Res,2005,97(1):25-34.
  • 7Dahl TB,Yndestad A,Skjelland M,et al.Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis:possible role in inflammation and plaque destabilization[J].Circulation,2007,115(8):972-980.
  • 8Adya R,Tan BK,Punn A,et al.Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways:novel insights into visfatin-induced angiogenesis[J].Cardiovasc Res,2008,78(2):356-365.
  • 9李骊华,雷寒.基质金属蛋白酶-9与动脉粥样硬化及斑块稳定性[J].中国老年学杂志,2009,29(6):771-773. 被引量：6

二级参考文献23

  • 1董波,赵玉霞,颜兆文,陈玉英,宋怀东,黄定九.基质金属蛋白酶-3蛋白及基因在动脉硬化血管中表达意义的研究[J].临床心血管病杂志,2004,20(9):546-548. 被引量：11
  • 2Newby AC.Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture〔J〕.Physiol Rev,2005;85(1):1-31.
  • 3Chow AK,Cena J,Schulz R.Acute actions and novel targets of matrix metalloproteinases in the heart and vasculature〔J〕.Br J Pharmacol,2007;152(2):189-205.
  • 4Kuge Y,Takai N,Ishino S,et al.Distribution profiles of membrane type-1 matrix metalloproteinase (MT1-MMP),matrix metalloproteinase-(MMP-2) and cyclooxygenase-2 (COX-2) in rabbit atherosclerosis:comparison with plaque instability analysis〔J〕.Biol Pharm Bull,2007;30(9):1634-40.
  • 5Zouridakis E,Avanzas P,Arroyo-Espliguero R,et al.Markers of inflammation and rapid coronary artery disease progression in patients with stable angina pectoris〔J〕.Circulation,2004;110(13):1747-53.
  • 6Manginas A,Bei E,Chaidaroglou A,et al.Peripheral levels of matrix metalloproteinase-9,interleukin-6,and C-reactive protein are elevated in patients with acute coronary syndromes:Correlations with serum troponinI〔J〕.Clin Cardiol,2005;28(4):182-6.
  • 7Funayama H,Ishikawa SE,Kubo N,et al.Increases in interleukin-6 and matrix metalloproteinase-9 in the infarct-related coronary artery of acutemyocardial in farction〔J〕.Circ J,2004;68(5):451-4.
  • 8Inokubo Y,Hanada H,Ishizaka H,et al.Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndrome〔J〕.Am Heart J,2001;141(2):211-7.
  • 9Uzui H,Harpf A,Liu M,et al.Increased expression of membrane type 3-matrix metalloproteinase in human atherosclerotic plaque:role of activated macrophages and inflammatory cytokines〔J〕.Circulation,2002;106:3024-30.
  • 10Loftus IM,Naylor AR,Goodall S.Increased matrix metalloproeinase-9 activity in unstable carotid plaque.A potential role on acute plaque disruption〔J〕.Stroke,2003;31(1):40-7.

共引文献5

蚌埠医学院学报
2011年 第12期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部